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Method: The Stimulant Expectancy Questionnaire for Men who have Sex with Men 
(SEQ‐MSM)	was	 initially	generated	through	consumer	panel	and	 interviews	regard‐
ing	 the	most	 commonly	 used	 stimulants	 among	MSM	 in	Australia	 (methampheta‐




Results: EFA	 revealed	 three	distinct	 substance	 reinforcement	 domains	 (‘Enhanced	
sexual	 experience’,	 ‘Sexual	 communication	 and	 negotiation’	 and	 ‘Cognitive	 impair‐
ment’).	 The	 scale	 was	 associated	 with	 stimulant	 consumption	 patterns	 (including	
greater	 expectancies	 regarding	 sexual	 enhancement	 among	 methamphetamine	
users),	and	the	factor	structure,	comprising	a	final	form	of	the	MSM‐SEQ,	was	con‐
firmed	through	CFA.
Conclusions: The	 SEQ‐MSM	 represents	 a	 reliable	measure	 of	 outcome	 expectan‐
cies	 related	 to	 the	 range	 of	 commonly	 used	 stimulants	 among	 Australian	 MSM.	









Substance‐related	 expectancies	 are	 associated	 with	 substance	 use	 and	 postsub‐
stance	use	thoughts,	feelings	and	behaviours.	Expectancies	held	by	specific	cultural	
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1  | INTRODUC TION
A	 growing	 body	 of	 research	 indicates	 associations	 between	 stim‐
ulant	 use	 and	 condomless	 anal	 sex	 (CAS)	 among	 men	 who	 have	
sex	 with	 men	 (MSM)1	 a	 primary	 risk	 factor	 for	 HIV	 transmission.	
Understanding	 the	 factors	 underlying	 stimulant	 use	 and	 sexual	
activity	 is	 crucial	 to	 reducing	 harm,	 regarding	 both	 stimulant	 use	
and	HIV	 transmission.2,3	MSM	have	 reported	higher	 rates	 of	 sub‐
stance	 misuse,	 including	 amphetamines	 compared	 to	 the	 general	
population.4,5	Substance	use	is	associated	with	social	contexts	and	
practices	 that	 enhance	 sexual	 experiences	 including	 ‘chemsex’.6,7 
Expectations	about	the	effects	of	stimulants,	as	well	as	the	contexts	
of	drug	use,	impact	on	whether	or	not	drugs	are	used	during	sex.8
Previous	 research	 demonstrates	 an	 association	 between	 ex‐
pectancies	and	substance	use	among	members	of	the	general	pop‐
ulation.9,10Expectancies’	 are	 a	 key	 component	 of	 Social	Cognitive	
Theory	for	predicting	health	behaviours	and	refer	to	expectations	
an	 individual	 holds	 about	 the	effects	of	 substance	use	on	 subse‐
quent	behaviours,	thoughts	and	mood;	and	are	distinct	from	other	
psychological	 constructs	 (eg,	 sensation‐seeking,	 motives,	 self‐ef‐
ficacy).	 The	 predictive	 utility	 of	 expectancies	 is	 specific	 to	 drug	
classes,	 and	 similarities	 and	 differences	 in	 expectancy	 profiles	
have	 been	 effectively	 demonstrated	 across	 substance	 types.11‒14 
Expectancies	are	hypothesised	as	a	key	mediating	variable	regard‐
ing	 substance	 use	 and	 sexual	 activity	 as	 well	 as	 secondary	 sub‐





Use	 of	 stimulants,	 such	 as	 methamphetamine,	 is	 associated	
with	 sexual	 activity	 including	 increased	 desire	 and	 disinhibition,17 
and	 heightened	 susceptibility	 to	 sexually	 transmissible	 infections/
HIV.18	Limited	mixed‐method	studies	have	explored	specific	 types	
of	 perceived	 stimulant	 consequences	 among	MSM	 (eg,	 ecstasy).19 
However,	 the	 hypothesised	 meditational	 role	 of	 expectancies	 in	
stimulant	 use	 and	 sexual	 activity,	 including	 CAS,	 cannot	 be	 suffi‐
ciently	 tested	as	no	known	suitable	expectancy	measure	exists	 to	
date.	This	 study	aims	 to	develop	a	 culturally	 appropriate	and	psy‐
chometrically	 robust	measure	of	expectancies	associated	with	 the	






















were	used	 in	Study	2	 to	distinguish	distinct	domains	of	 reinforce‐


















used	stimulants.	The Stimulant Expectancy Questionnaire for Men who have Sex with Men 
(SEQ‐MSM)	examines	the	most	commonly	used	stimulants	among	MSM	in	Australia.
K E Y W O R D S
factor	analysis,	methamphetamine,	sexual	behaviour,	sexual	minorities,	substance‐related	
disorders
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Ninety‐two	of	participants	indicated	Anglo‐Australian	for	ethnic	
background	and	the	remaining	8%	of	participants	 identified	as	be‐
longing	 to	 ‘Other’	 as	 their	 ethnic	 group.	No	 participants	 reported	
their	identity	as	Aboriginal	or	Torres	Strait	Islander.	All	participants	




We	used	 the	44	 item	version	of	 the	 SEQ‐MSM	 (full	methodology	
for	 item	generation	described	elsewhere).22‒24	These	 items	tapped	
three	 domains	 of	 stimulant	 expectancy:	 ‘enhanced	 sexual	 experi‐
ence’	(ESE),	‘sexual	communication	and	negotiation’	(SCN),	and	cog‐







enhanced	 communication	 and	 negotiation	 and	 cognitive	 impair‐





The	 44‐item	 version	 of	 the	 SEQ‐MSM	 was	 completed	 online	 by	
a	 community	 sample	 of	 MSM	 in	 Australia.	 Participants	 were	 re‐











kurtosis	were	examined	 resulting	 in	27	 items	being	 removed	 from	










within	 the	 first	 content	 dimension,	 ‘enhanced	 sexual	 experience,’	
displayed	moderate	 to	high	 item‐total	correlations	 (0.71–0.81)	and	
together	as	a	subscale	displayed	a	high	alpha	level	of	0.90.	Four	of	













Across	all	 three	of	 the	 subscales	 (enhanced	 sexual	experience,	











of	 the	SEQ‐MSM	with	a	much	 larger	 sample.	The	13‐item	version	
of	the	SEQ‐MSM	completed	online	by	a	community	sample	of	427	
MSM	in	Australia,	recruited	through	advertisements	in	GLBTIQ	or‐
ganisations	and	social	media/venues.	This	 sample	 represented	 the	







Table	1	 for	all	 items).	All	 items	were	measured	on	a	5‐point	Likert	
scale	ranging	from	Strongly	Agree	to	Strongly	Disagree,	with	agree‐
ment	 indicating	 enhanced	 experience,	 enhanced	 communication	
and	negotiation	and	cognitive	impairment.	Negatively	worded	items	






quired	 approximately	 30	minutes	 to	 complete.	 The	data	 revealed	
responses	 missing	 completely	 at	 random	 for	 less	 than	 3%	 of	 re‐
spondents.	These	were	 replaced	via	multiple	 imputation	 to	 result	
in	 complete	data	 for	427	 respondents.	Cases	were	 then	assigned	
a	random	number	between	−3.06	and	2.58	(M	=	0.02,	SD	=	0.96).	
Cases	with	negative	 random	numbers	 (N	=	202)	were	 split	 into	a	
separate	file	for	exploratory	factor	analysis	(EFA),	while	cases	with	
a	positive	value	(N	=	225)	were	retained	in	a	separate	file	for	con‐
firmatory	 factor	 analysis	 (CFA).	To	 check	 for	 true	 random	assign‐
ment,	we	computed	subscale	means	for	each	of	the	three	subscales	





was	 insignificant	 (t	=	1.63,	P	>	0.10).	Finally,	 for	 the	cognitive	 im‐
pairment	subscale	the	difference	in	means	(0.14,	[−0.04,	0.34])	was	
TA B L E  1   Item	analyses
Study 1




5 3.55 1.13 −0.48 −0.50 0.73 Sex	is	better	when	using	stimulants
13 3.50 1.19 −0.50 −0.62 0.43 I	think	a	lot	more	about	sex	when	using	
stimulants
17 3.68 1.06 −0.53 −0.11 0.72 Using	stimulants	makes	sex	last	longer
33 3.54 1.11 −0.61 −0.21 0.81 I	feel	more	stimulation	and	sensations	during	
sex	when	I	am	using	stimulants
37 3.65 1.12 −0.63 −0.21 0.76 I	have	more	adventurous	sex	when	I	am	using	
stimulants
41 3.53 1.22 −0.63 −0.59 0.71 I	am	more	likely	to	go	looking	for	sex	when	I	
have	been	using	stimulants
Sexual	communication	and	negotiation	α	=	0.69	(all	items)/α	=	0.84	(after	deleting	item	14)
14 3.39 1.03 −0.55 −0.03 0.27* Conversations	are	better	when	using	
stimulants
18 2.53 1.22 0.53 −0.73 0.65 I	am	less	likely	to	ask	for/discuss	condoms	if	I	
have	been	using	stimulants
23 2.42 1.23 −0.58 −0.67 0.57 I	am	more	likely	to	assume	the	other	
person	is	the	same	HIV	status	when	using	
stimulants
42 2.50 1.18 0.52 −0.43 0.63 I	am	less	likely	to	discuss	my/my	partner's	
HIV	status	with	my	partner	during	sex	when	
I	have	been	using	stimulants
44 2.42 1.26 0.66 −0.65 0.65 When	I	am	using	stimulants	I	may	think	
unsafe	sex	is	okay	at	the	time
Cognitive	impairment	α	=	0.73	(all	items)/α	=	0.75	(after	deleting	items	9	and	36)
9 2.94 0.97 0.20 −0.60 0.13* I	see	things	more	clearly	when	using	
stimulants
22 3.42 1.08 −0.50 −0.64 0.37 My	judgement	can	become	impaired	when	
using	stimulants
31 2.65 1.14 0.39 −0.61 0.51 I	can	become	paranoid	or	suspicious	after	
using	stimulants
36 3.96 0.77 −0.62 0.41 0.28* My	emotions	are	heightened	when	using	
stimulants
40 3.12 1.06 −0.31 −0.59 0.38 I	feel	more	accepted	by	people	when	using	
stimulants
Note:	N	=	98.	Asterisk indicates items marked for deletion.
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insignificant	 (t	=	1.46,	P	>	0.10).	These	checks	provided	evidence	




Descriptive	 statistics	 are	 reported	 for	 the	 EFA	 data	 in	 Table	 2.	
The	13	items	retained	from	Study	1	were	analysed	using	explora‐
tory	factor	analysis	with	multiple	likelihood	extraction	(N	=	202).	









cuss	 condoms	when	 I	 have	been	using	 stimulants’),	 accounted	 for	
12.8%	of	the	total	variance.	Factor	3,	CI	(eg,	‘My	judgement	can	be‐
come	 impaired	when	using	stimulants’),	 accounted	 for	7.1%	of	 the	
total variance.
Zero‐order	 correlations	 were	 produced	 across	 the	 factor	
scores	with	a	mean	of	 r	=	0.47	 (range	=	0.45–0.55).	The	 internal	
reliability	of	each	factor	was	assessed	using	Cronbach's	alpha,	with	
an	overall	mean	of	.81.	Factors	1	(0.93)	and	2	(0.82)	demonstrated	
a	 high	 level	 of	 internal	 consistency,	 and	 Factor	 3	 (0.66)	was	 ac‐
ceptable.	Split‐half	 reliability	analyses	were	conducted	using	 the	
Guttman	Split‐Half	coefficient,	with	a	mean	of	r	=	0.83	across	all	
factors.	 Factors	 1	 (0.94)	 and	 2	 (0.89)	 demonstrated	 a	 high	 split‐
half	reliability;	Factor	3	(0.65)	demonstrated	acceptable	split‐half	
reliability.
TA B L E  2  Descriptive	statistics	and	correlations	for	EFA	sample
Study 2




5 3.55 1.13 −0.48 −0.50 0.83 Sex	is	better	when	using	stimulants
13 3.50 1.19 −0.50 −0.62 0.85 I	think	a	lot	more	about	sex	when	using	
stimulants
17 3.68 1.06 −0.53 −0.11 0.76 Using	stimulants	makes	sex	last	longer
33 3.54 1.11 −0.61 −0.21 0.86 I	feel	more	stimulation	and	sensations	dur‐
ing	sex	when	I	am	using	stimulants
37 3.65 1.12 −0.63 −0.21 0.81 I	have	more	adventurous	sex	when	I	am	
using	stimulants
41 3.53 1.22 −0.63 −0.59 0.80 I	am	more	likely	to	go	looking	for	sex	when	
I	have	been	using	stimulants
Sexual	communication	and	negotiation	α	=	0.85
18 2.53 1.22 0.53 −0.73 0.77 I	am	less	likely	to	ask	for/discuss	condoms	if	
I	have	been	using	stimulants
23 2.42 1.23 −0.58 −0.67 0.56 I	am	more	likely	to	assume	the	other	
person	is	the	same	HIV	status	when	using	
stimulants
42 2.50 1.18 0.52 −0.43 0.69 I	am	less	likely	to	discuss	my/my	partner's	
HIV	status	with	my	partner	during	sex	
when	I	have	been	using	stimulants
44 2.42 1.26 0.66 −0.65 0.75 When	I	am	using	stimulants	I	may	think	
unsafe	sex	is	okay	at	the	time
Cognitive	impairment	α	=	0.69
22 3.42 1.08 −0.50 −0.64 0.57 My	judgement	can	become	impaired	when	
using	stimulants
31 2.65 1.14 0.39 −0.61 0.48 I	can	become	paranoid	or	suspicious	after	
using	stimulants
40 3.12 1.06 −0.31 −0.59 0.45 I	feel	more	accepted	by	people	when	using	
stimulants
Note:	N	=	202.
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4.2 | Confirmatory factor analysis
Descriptive	statistics	are	reported	for	the	second	dataset,	which	we	






We	 conducted	 a	 CFA	 using	 IBM	 SPSS	 Amos	 (version	 25)	 and	
modelled	the	factors	for	the	ESE,	SCN	and	CI	subscales	as	latent	vari‐
ables,	with	the	12	items	retained	after	the	EFA	as	manifest	variables.	












Using	 such	 guidelines,	 the	 CFA	 fit	 indices	 indicated	 good	 to	
acceptable	 fit	 to	 the	model	 (SRMR	=	0.05,	NFI	=	0.92,	CFI	=	0.95,	
TLI	=	0.93,	and	RMSEA	=	0.09).	 In	addition,	 fit	 for	 this	model	was	
superior	 to	a	single	 factor	model	of	stimulant	expectancies,	which	
displayed	 unacceptable	 fit	 (SRMR	 =	 0.10,	 NFI	 =	 0.76,	 CFI	 =	 0.78,	
TLI	=	0.74,	 and	RMSEA	=	0.17).	All	parameter	estimates	 indicated	










The	 SEQ‐MSM	 was	 developed	 within	 the	 MSM	 community	 in	
Australia	 from	 the	 ‘ground	 up’,	 using	 rigorous	 methodology	 and	
measure	 development	while	 working	 in	 partnership	with	 commu‐
nity	members	and	peak	body	organisations	in	this	area.	As	such,	the	
scale	developed	is	both	considered	to	be	relevant,	appropriate	and	









5 Sex	is	better	when	using	stimulants 0.92 0.00 −0.12
13 I	think	a	lot	more	about	sex	when	using	stimulants 0.84 0.01 0.07




















22 My	judgement	can	become	impaired	when	using	stimulants 0.14 0.18 0.49
31 I	can	become	paranoid	or	suspicious	after	using	stimulants −0.01 0.01 0.72













relative	 independence,	was	 confirmed	by	 inter‐factor	 correlational	
data,	calculation	of	factor	 loadings,	and	 inter‐total	correlations.	All	











ulation,	 the	SEQ‐MSM	has	a	 focus	on	 sexual	 activity	and	 sexual	
risk‐taking.16	 Compared	 to	 other	 limited	 research	 on	 expectan‐
cies	 among	MSM,	 the	SEQ‐MSM	has	been	developed	a	priori	 in	
conjunction	 with	 members	 of	 the	 target	 group	 and	 includes	 a	
wider	 range	 of	 stimulants	 commonly	 used.30	 Furthermore,	 com‐












TA B L E  4  Descriptive	statistics	and	correlations	for	Confirmatory	Factor	Analysis	(CFA)
Study 2




5 3.20 1.13 −0.29 −0.45 0.80 Sex	is	better	when	using	stimulants
13 3.45 1.18 −0.42 −0.51 0.84 I	think	a	lot	more	about	sex	when	using	
stimulants
17 3.39 1.14 −0.45 −0.39 0.75 Using	stimulants	makes	sex	last	longer
33 3.34 1.21 −0.43 −0.66 0.84 I	feel	more	stimulation	and	sensations	during	
sex	when	I	am	using	stimulants
37 3.42 1.23 −0.54 −0.54 0.83 I	have	more	adventurous	sex	when	I	am	using	
stimulants
41 3.22 1.27 −0.34 −0.80 0.75 I	am	more	likely	to	go	looking	for	sex	when	I	
have	been	using	stimulants
Sexual	communication	and	negotiation	α	=	0.82
18 2.74 1.23 0.11 −0.92 0.72 I	am	less	likely	to	ask	for/discuss	condoms	if	I	
have	been	using	stimulants
23 2.72 1.14 −0.02 −0.73 0.51 I	am	more	likely	to	assume	the	other	
person	is	the	same	HIV	status	when	using	
stimulants
42 2.77 1.16 −0.02 −0.77 0.68 I	am	less	likely	to	discuss	my/my	partner's	
HIV	status	with	my	partner	during	sex	when	
I	have	been	using	stimulants
44 2.81 1.25 −0.01 −1.05 0.66 When	I	am	using	stimulants	I	may	think	
unsafe	sex	is	okay	at	the	time
Cognitive	impairment	α	=	0.66
22 3.60 1.10 −0.79 −0.16 0.50 My	judgement	can	become	impaired	when	
using	stimulants
31 2.72 1.19 0.14 −0.88 0.50 I	can	become	paranoid	or	suspicious	after	
using	stimulants
Note:	N	=	225.









ing	 other	means	 to	 enhance	 sex	 that	 do	 not	 include	 stimulants,	
discussing	 condom	use	 or	HIV	 status	with	 sexual	 partners	 prior	
to	 using	 stimulants,	 providing	 health	 and	 assess	 information	 re‐
garding	 PrEP	 among	 stimulant	 users).	 Focusing	 on	 reducing	 use	
and	 modifying	 expectancies	 could	 be	 a	 useful	 target	 regarding	
HIV	 prevention.	 Furthermore,	 difficulties	 regarding	 sexual	 com‐
munication	and	negotiation	may	have	developed	secondary	to	low	










to	 problems	 with	 communication,	 focusing	 on	 improving	 commu‐
nication	about	HIV	status,	viral	 load	and	negotiating	sexual	activity	
with	a	perspective	partner	before	using	stimulants.	It	could	also	allow	
for	 education	 about	potential	 harms	 so	 that	people	 are	making	 in‐
formed	decisions	about	their	use.	It	can	also	help	raise	public	aware‐
ness	 among	 MSM	 around	 judgement,	 stigma	 and	 impact.	 Greater	
promotion	 and	utilisation	of	PrEP	and	 routine	HIV	 testing	 are	 also	
useful	targets	for	future	interventions.40,41	It	can	be	argued	from	the	
results	from	the	current	study	that	given	the	role	of	stimulant	use	and	







treatment	 approaches	 (including	 brief	 interventions)	 could	 include	
challenging	and	modifying	expectancies	in	other	community	and	clin‐
ical	interventions.46,47
Identifying	 MSM	 who	 use	 stimulants	 concurrently	 with	 CAS	
would	be	a	useful	target	for	preventative	education,	and	the	SEQ‐










5.2 | Limitations and future research
Sampling	via	self‐selection	may	have	attracted	a	more	motivated	
group,	 and	 recruitment	 specifically	 regarding	 substance	 use	
may	have	disproportionately	 attracted	MSM	who	more	heavily	
use	 and	may	 not	 be	 necessarily	 representative	 of	 a	 cross	 sec‐
tion	 of	 MSM.	 Recruiting	 participants	 through	 gay	 community	
networks	 could	 have	 resulted	 in	 nonidentifying	 MSM	 being	
underrepresented.





F I G U R E  1  Study	2:	Three‐factor	structure	for	the	revised	
SEQ‐MSM	final	form
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unclear	if	substances	are	part	of	an	active	strategy	to	reduce	self‐
awareness/responsibility	 regarding	 sexual	 activity,48	 or	 a	 subse‐
quent	attribution	for	behaviour	while	under	the	influence.	Other	
unmeasured	 factors	 also	 contribute	 to	 perceived	 consequences	
(eg,	 self‐efficacy	 regarding	condom	use).49	The	 term	 ‘unsafe	sex’	
was	 also	 included	 in	 the	 measure	 as	 it	 was	 based	 on	 the	 focus	
group	testing	with	the	target	group,	however	the	more	commonly	
used	 term	 in	 this	 field	 is	 ‘condomless	 sex’.	 As	 such,	 future	 iter‐
ations	 will	 consider	 modifying	 this	 term	 to	 more	 contemporary	
terminology.
Future	 research	 should	 consider	 other	 key	 factors	 that	
contribute	 to	 the	 reported	 outcomes,	 such	 as	 stigma	 and	 low	
self‐confidence,	and	relationships	between	sexual	arousal	and	de‐
cision‐making	 among	MSM	 in	 conjunction	 with	 substance	 use30 
in	general	 and	within	 ‘chemsex’	 environments,	 including	 the	 role	






sexual	 activity	 (in	 addition	 to	 the	 perceived	 effects	 of	 stimulant	
use	on	 sexual	 activity).	 Investigating	a	wider	 range	of	 stimulants	







This	 study	 provides	 an	 important	 advance	 into	 understanding	
perceived	 reinforcement	 among	 stimulant	 users,	 and	 identified	
a	range	of	consequences	of	stimulant	use	among	MSM,	and	pro‐
vides	 a	measure	 specific	 to	MSM	 for	 future	 research.	 Findings	
from	 the	 current	 study	 lend	 support	 for	 the	 role	 of	 expectan‐
cies	 regarding	sexual	activity,	 including	 factors	associated	with	
HIV	 transmission	 and	 targets	 for	 future	 prevention	 and	 health	
promotion.
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